Cuprina jumps after Nasdaq compliance update, but risks remain

Cuprina Holdings Limited shares jumped Friday after the biomedical firm said it is back in line with Nasdaq Capital Market rules, easing delisting worries. The Singapore-based company’s Nasdaq-listed stock was recently at $4.20, up roughly 74% from the previous close, and traded between $2.33 and $7.91 in heavy volume, with about 79.3 million shares changing hands.